Simeon George, M.D.
Lead Independent DirectoratDesign Therapeutics· In proxies 2023–2025
Simeon George, M.D. sits on 8 public boards.
Boards1
- Design TherapeuticsLead independent director · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Design TherapeuticsPublic company · 3 yr
- Lead Independent Director2023 – Present · 3 yrStock in role +21%
- Nkarta, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- CRISPR Therapeutics AGPublic company · 11 yr
- Director2015 – Present · 11 yrNo stock prices for these years
- Turning Point Therapeutics, Inc.Public company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Principia Biopharma Inc.Public company · 15 yr
- Director2011 – Present · 15 yrNo stock prices for these years
- Arcellx, Inc.Public company · 2 yr
- Director2015 – 2017 · 2 yrNo stock prices for these years
- HTG Molecular Diagnostics, Inc.Public company · 4 yr
- Director2011 – 2015 · 4 yrNo stock prices for these years
- Genocea Biosciences, Inc.Public company · 5 yr
- Director2009 – 2014 · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?